Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carlos Rodriguez-Escalera"'
Autor:
Maria Luque-Tévar, Carlos Perez-Sanchez, Alejandra Mª Patiño-Trives, Nuria Barbarroja, Ivan Arias de la Rosa, Mª Carmen Abalos-Aguilera, Juan Antonio Marin-Sanz, Desiree Ruiz-Vilchez, Rafaela Ortega-Castro, Pilar Font, Clementina Lopez-Medina, Montserrat Romero-Gomez, Carlos Rodriguez-Escalera, Jose Perez-Venegas, Mª Dolores Ruiz-Montesinos, Carmen Dominguez, Carmen Romero-Barco, Antonio Fernandez-Nebro, Natalia Mena-Vazquez, Jose Luis Marenco, Julia Uceda-Montañez, Mª Dolores Toledo-Coello, M. Angeles Aguirre, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Chary Lopez-Pedrera
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Background: This prospective multicenter study developed an integrative clinical and molecular longitudinal study in Rheumatoid Arthritis (RA) patients to explore changes in serologic parameters following anti-TNF therapy (TNF inhibitors, TNFi) and b
Externí odkaz:
https://doaj.org/article/bb017e91ba5d4f1ebf7fe17dc8217b1e
Autor:
Laura Muñoz-Barrera, Carlos Perez-Sanchez, Rafaela Ortega-Castro, Sagrario Corrales, Maria Luque-Tevar, Tomás Cerdó, Ismael Sanchez-Pareja, Pilar Font, Raquel Lopez-Mejías, Jerusalem Calvo, M.Carmen Abalos-Aguilera, Desiree Ruiz-Vilchez, Pedro Segui, Christian Merlo, José Perez-Venegas, Ma Dolores Ruiz Montesino, Carlos Rodriguez- Escalera, Carmen Romero Barco, Antonio Fernandez-Nebro, Natalia Mena Vazque, Jose Luis Marenco, Julia Uceda Montañes, Javier Godoy-Navarrete, Alba Ma Cabezas-Lucena, Eduardo Collantes Estevez, Ma Angeles Aguirre, Miguel A. González-Gay, Nuria Barbarroja, Alejandro Escudero-Contreras, Chary Lopez-Pedrera
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 173, Iss , Pp 116357- (2024)
Background & objectives: This study aimed to: 1) analyze the inflammatory profile of Rheumatoid Arthritis (RA) patients, identifying clinical phenotypes associated with cardiovascular (CV) risk; 2) evaluate biologic and targeted-synthetic disease-mod
Externí odkaz:
https://doaj.org/article/085892cf1b36456385f1204967d195fa
Autor:
Alejandra M. Patiño-Trives, Chary López-Pedrera, José Luis Marenco, Rafaela Ortega-Castro, Carlos Perez-Sanchez, M. Romero-Gómez, Iván Arias de la Rosa, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Natalia Mena-Vázquez, Nuria Barbarroja, Pilar Font, Antonio Fernández-Nebro, J.J. Pérez-Venegas, Desiree Ruiz-Vilchez, Carmen Dominguez, M. D. C. Abalos-Aguilera, C.M. Romero-Barco, Juan Antonio Marin-Sanz, M. Angeles Aguirre, Carlos Rodriguez-Escalera, Mª Dolores Ruiz-Montesinos, Julia Uceda-Montañez, María Luque-Tévar, Mª Dolores Toledo-Coello, Clementina López-Medina
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Background: This prospective multicenter study developed an integrative clinical and molecular longitudinal study in Rheumatoid Arthritis (RA) patients to explore changes in serologic parameters following anti-TNF therapy (TNF inhibitors, TNFi) and b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c31926dfb67e1ee0c95786a3c508bf57